A pragmatic randomized trial of mailed fecal immunochemical testing to increase colorectal cancer screening among low‐income and minoritized populations in San Diego County
Conference: International Conference on Health Policy Statistics 2025
01/07/2025: 4:00 PM - 4:30 PM PST
Special Event
Colorectal cancer (CRC) screening can reduce morbidity and mortality but is underused, particularly among low-income and some minoritized populations. Mailed fecal immunochemical testing (FIT) is an evidence-based strategy to increase colorectal cancer (CRC) screening. We tested a multi-level mailed FIT intervention in 3 community health center (CHC) systems in San Diego County using a cluster-randomized trial design. Multi-level implementation strategies were utilized to increase CRC screening uptake. Among 26,736 participants who met eligibility criteria, approximately 58% were female, 55% were Hispanic individuals, and 44% were Spanish speaking. The proportion completing screening was 11.5 percentage points (ppts) (95% CI, 6.1–16.9 ppts) higher in intervention versus usual care clinics. Variation in differences between intervention and usual care clinics was observed by racial and ethnic group (13.8 ppts [7.0–20.6 ppts] for Hispanics; 13.0 ppts [3.6–22.4 ppts] for Asians; 11.3 ppts [5.8–16.8 ppts] for non‐Hispanic Whites; 6.1 ppts [0.8–10.4 ppts] for Blacks). These results show that a regional mailed FIT intervention was effective for increasing CRC screening rates across CHC systems serving diverse, low‐income populations.
Speaker
Elena Martinez, UCSD
You have unsaved changes.